Altria Invests $2.4 Billion into Cronos Group: CRON Stock is Soaring

CRON Stock

It’s an investment that has brought the cannabis market back to life. Today, Altria Group (NYSE:MO)—the makers of Marlboro cigarettes—confirmed a $2.4 billion investment deal with Cronos Group (TSX:CRON) (NASDAQ:CRON). CRON stock is soaring as a result, and it seems to be taking the entire market with it. 

This deal is huge.

Altria is In and CRON Stock Soars

Rumors abounded during the week as the Canadian cannabis producer revealed that the two companies were “in talks.” Much to investors delight, it’s been confirmed that Altria has bought a 45% stake in the company.

In fact, CRON stock is soaring over 25% at the time of writing, currently selling for $12.94 USD.

The Deal

The deal will see Altria buy 146.2 million newly issued CRON shares at $16.25 per share. This is a premium of 16.2% to the stock’s Thursday close on the Toronto Stock Exchange.

Once the deal closes, Altria will be allowed to nominate four directors and one independent to the Cronos board.

Further, Altria may raise its ownership stake to 55% as the deal includes a warrant to acquire an additional ownership interest in Cronos at a price of $19 per share over the next four years.

What Does This Mean?

This is big news, and this is now an important time for CRON stock. 

Capitalize off Cannabis
Sign up now to start receiving our investing insights for FREE!


The deal marks the tobacco maker’s first step into the cannabis industry and shows that it believes marijuana to be the next area for growth. Especially considering tobacco sales have slowed in recent years. So much so, in fact, that Altria stock has fallen nearly 25% this year. 

It is time to evolve it seems. 

>> Marijuana Stocks: Are You Put Off By the Market Correction?


With this deal, the Marlboro cigarette maker is now entering a rapidly growing legal marijuana industry. Its entry is sure to inspire others in the tobacco industry to follow suit. Much like the ripple that was caused by Constellation Brands’ (NYSE:STZ) massive $4 billion investment into Canopy Growth (TSX:WEED) (NYSE:CGC).

On the deal, Howard Willard, Altria CEO, said the following:

“Investing in Cronos Group as our exclusive partner in the emerging global cannabis category represents an exciting new growth opportunity for Altria.”

And Cronos CEO Mike Gorenstein shares the same sentiment:

“Altria is the ideal partner for Cronos Group, providing the resources and expertise we need to meaningfully accelerate our strategic growth.”

Having Altria in its corner is a big win for CRON stock. Altria brings with it years of global expertise, well-known global brands, and a loyal consumer base. For a relatively young industry, by comparison, it’s sort of like adding Mr. Miyagi to your karate squad.

>> Green Growth Brands Awarded 7 New Retail Licenses in Nevada

Another cannabis company to get some great news today is Green Growth Brands (CSE:GGB) (OTC:XTHCF). The state of Nevada today awarded seven new dispensary licenses to GGB! The state made available a possible 31 new licenses across the state.

In September of this year, Green Growth Brands raised $65 million in its efforts to go public. The company was backed by the Schottenstein family; one of America’s oldest fashion retail families. The Schottenstein’s fortune, approximated at $2.7 billion, has been amassed from real estate holdings, part ownership in DSW Inc. a shoe retailer, and of huge clothing label American Eagle Outfitters. The Schottenstein family are deeply involved in Green Growth Brands with Barbara Schottenstein serving as a director at GGB. 

With backing from such a retail giant, it seems that GGB is in incredibly good stead and now, the company is set for an amazing opportunity. Nevada is the US’ second largest cannabis market, only falling behind California. In the first year of legalization alone, Nevada State made $530 million on recreational and medicinal cannabis sales. In August 2018, Nevada’s marijuana tax revenues broke the $8 million mark.

The state previously had only 65 licensed dispensaries with Green Growth Brands running 2 flagship stores in Las Vegas, The Premier Cannabis Store, and The Source. These new licenses bring the company’s potential up to 9 possible retail spaces. License holders have to be operational within 12 months which means that by the end of 2019, Green Growth Brands could be sitting on a very large revenue nest egg. If revenue is growing, it seems that GGB stocks should follow suit.

Featured Image: Depositphotos/© VadimVasenin

Please See Disclaimer


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Green Growth Brands Ltd. Market Jar Media Inc. has or expects to receive the following amounts from Native Ads Inc. in the amount of one hundred thousand dollars for 21 campaign days (14 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Market Jar Media Inc. should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Market Jar Media Inc.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.